Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
Under 67% of Tianyin Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Tianyin Pharmaceutical Co suggests that many traders are alarmed regarding Tianyin Pharmaceutical's prospects. Tianyin Pharmaceutical's investing sentiment shows overall attitude of investors towards Tianyin Pharmaceutical Co.
Tianyin |
Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 agonist, in acutely sleep-deprived...
Read at globenewswire.com
Tianyin Pharmaceutical Fundamental Analysis
We analyze Tianyin Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tianyin Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tianyin Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Tianyin Pharmaceutical is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Tianyin Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tianyin Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Tianyin Pharmaceutical Related Equities
MMSI | Merit Medical | 0.90 | ||||
CNNE | Cannae Holdings | 0.18 | ||||
SHAK | Shake Shack | 0.18 | ||||
KRUS | Kura Sushi | 2.73 | ||||
TXRH | Texas Roadhouse | 3.44 | ||||
SSY | SunLink Health | 3.49 | ||||
CNTA | Centessa Pharmaceuticals | 5.36 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Directory Find actively traded commodities issued by global exchanges |